COVID-19 puts lung transplant recipients at high risk regardless of vaccination status

NASHVILLE, Tenn. — Lung transplant recipients with COVID-19 appear to have increased risk for mortality and sustained lung function decline regardless of vaccination status, according to study results presented at the CHEST Annual Meeting.
“With the advent of the mRNA vaccine in 2020, we know that this led to less hospitalization, less disease progression, less risk of death,” Alan S. Nyquist, MD, advanced lung disease and lung transplant physician at Inova Fairfax Hospital in Falls Church, Virginia, said during the presentation. “However, even in our population of

NASHVILLE, Tenn. — Lung transplant recipients with COVID-19 appear to have increased risk for mortality and sustained lung function decline regardless of vaccination status, according to study results presented at the CHEST Annual Meeting.
“With the advent of the mRNA vaccine in 2020, we know that this led to less hospitalization, less disease progression, less risk of death,” Alan S. Nyquist, MD, advanced lung disease and lung transplant physician at Inova Fairfax Hospital in Falls Church, Virginia, said during the presentation. “However, even in our population of